Susvimo Demonstrates Sustained Efficacy Over Two Years in Patients with Diabetic Macular Edema and Diabetic Retinopathy

Image credit: koolsabuy | stock.adobe.com Two-year data from the Phase III Pagoda and Pavilion studies demonstrate that Genentech’s Susvimo (ranibizumab) injection 100 mg/mL produced sustained efficacy in patients with diabetic macular edema (DME) and diabetic retinopathy (DR), respectively. The FDA accepted a supplemental Biologics License Application (sBLA) for Susvimo based on one-year results showing non-inferior […]

Continue Reading

Systech, Praxis Packaging Strike Track-and-Trace Partnership

Image Credit: Adobe Stock Images/VisualGeneration.com Systech, a provider of digital identification and traceability solutionsfor the pharma industry, was selected by Praxis Packaging Solutions to provide a track-and-trace platform for supply chain transparency.1 This partnership grants Praxis customers access to aggregation and product tracing services that are able to meet global compliance requirements, such as the […]

Continue Reading

Cordenpharma Invests $984 Million into Its Peptide Tech Platform

Image Credit: CordenPharma CordenPharma, a full-service contract development manufacturing organization (CDMO) of active pharmaceutical ingredients (APIs), excipients, drug products and packaging services, will invest approximately $984 million (€900 million) over the next three years in order to enhance its peptide technology platform.1 These initiatives feature two major expansion plans in the United States and Europe that […]

Continue Reading

Catalent Finalizes Schorndorf Plant Development Project

Image Credit: Business Wire, Catalent Catalent, a contract development and manufacturing organization (CDMO), has completed expansion of its clinical supply plant in Schorndorf, Germany.1 The Schorndorf site—which offers clinical supply services, such as packaging, storage and distribution— is considered the CDMO’s flagship European facility and has been in operation since 1996. The development project grows […]

Continue Reading

Upperton Pharma Solution Passes MHRA Inspection, Simultaneously Invests in Large-Scale Processing

Upperton Pharma Solutions’ large processing room. Image Credit: Upperton Pharma Solutions At its 50,000 square-foot development and current good manufacturing practice (cGMP) facility in Nottingham, UK, Upperton Pharma Solutions, a contract development and manufacturing organization (CDMO), has completed a Medicines and Healthcare products Regulatory Agency (MHRA) inspection.1 The inspection follows the completion of the construction, commissioning, […]

Continue Reading

INCOG BioPharma Invests in Second Manufacturing Building on Indiana Campus

Image Credit: Adobe Stock Images/Shutter2U.com INCOG BioPharma Services, a contract development and manufacturing organization (CDMO) whose focus is on sterile injectable biopharmaceuticals, is furthering its manufacturing services with the construction of a second 100,000 square-foot building on its campus in Fishers, IN.1 The project—scheduled to break ground in August—is expected to enhance the CDMO’s commercial-scale […]

Continue Reading

Technology Designed to Support Infertility, Patients with Type 1 Diabetes Have Higher Risk of Epilepsy & more

Femasys Founder Discusses Femaseed Technology Designed to Support Infertility In an interview with Pharm Exec Associate Editor Don Tracy, Kathy Lee-Sepsick, Founder, CEO, Femasys, offers a description of how Femaseed works to support women who struggle with infertility. Patients with Type 1 Diabetes Have Higher Risk of Epilepsy A new meta-analysis has showed that people […]

Continue Reading

Study Connects Multivitamin Use With Mortality Risk, Can Data and AI Deliver Whole-Person Health? & more

Can Data and AI Deliver Whole-Person Health? Executives in the life sciences and medical device industries see promise in artificial intelligence (AI) and medical technologies, but must also navigate the changing healthcare ecosystem, varied stakeholder needs, and the impact of AI on market access and commercialization strategies. Study Connects Multivitamin Use With Mortality Risk Daily […]

Continue Reading

Thermo Fisher Scientific Completes Acquisition of Olink, 7 Takeaways From the FTC Interim Report on PBMs & more

What is the Secret Sauce to Convert Academic Ideas to Valued Offerings That Prospective Buyers Crave? A Harvard Business School Healthcare Alumni Association Q&A with Penn Center for Innovation’s Michael D. Moisel, MS, MBA. Michael D. Poisel, MS, MBA, is responsible for managing Penn Center for Innovation (PCI) Ventures (PCIV), assisting the principal investigators with […]

Continue Reading

Merck Finalizes EyeBio Purchase

Image Credit: Adobe Stock Images/VictoriaKey.com Merck has now officially acquired Eyebiotech Limited (EyeBio), a clinical-stage ophthalmology biotech company.1 As a result of owning all of EyeBio’s outstanding shares, the deal is valued as high as $3 billion; this includes a cash payment of $1.3 billion, along with the possibility for an additional $1.7 billion in […]

Continue Reading

How State Privacy Laws Are Shaping DTC and HCP Marketing Strategies

New laws aimed at safeguarding personal information are reshaping how companies interact with consumers and healthcare professionals (HCPs). In this article, we’ll explore the challenges and opportunities presented by this new era of consumer privacy, providing a roadmap for navigating compliance complexities while connecting consumers to vital healthcare information. Overview of consumer privacy legislation and […]

Continue Reading

Rentschler Biopharma SE’s New Advanced Production Line Now Fully Operational

Image Credit: Adobe Stock Images/Kirill Gorlov Rentschler Biopharma SE, a contract development and manufacturing organization, announced that its new advanced production line in Milford, Massachusetts in now fully operational. According to the company, the product line represents the largest investment in its 150-year existence. Known as the Rentschler Biopharma Manufacturing Center, the facility reportedly doubles […]

Continue Reading

The State of Patient Support Services in Today’s Landscape

The fundamental goal of patient support programs—whether it’s a hub, patient assistance program (PAP), or adherence support services—is to expedite patient access to therapy. However, the reality of that goal sometimes falls short of expectations due to linear and rigid pathways, which can cause significant medication access delays. On average, some outdated patient support models […]

Continue Reading

The Current Landscape of Drug Shortages

PC: According to the American Society of Health-Pharmacists (ASHP), ongoing and active drug shortages are the highest they’ve been since the association began tracking this in 2001. Could you elaborate on why that is, along with sharing your thoughts on the current landscape of shortages in general? Ax: Well today, there are, by latest count, […]

Continue Reading

MedPharm, Tergus Pharma Join Forces

Image Credit: Adobe Stock Images/inimalGraphic.com MedPharm, Ltd. and Tergus Pharma, have decided to combine their efforts. Together, they are forming a topical and transepithelial contract development and manufacturing organization (CDMO) that will function under the MedPharm name.1 The end result is a CDMO that offers end-to contract services—including early phase research, formulation development, and in […]

Continue Reading

Air Freight Demand Continues for May

Although the calendar might indicate that Q3 2024 is officially underway, the International Air Transport Association (IATA) just released data for May 2024—as this in-depth analysis takes time to process—which point to global air cargo market demand maintaining its yearly growth in demand.1 Total demand, measured in cargo tonne-kilometers (CTKs), climbed by 14.7% compared to […]

Continue Reading

SGS North America Strengthens Its Biologics Testing Services

SGS North America—a company consisting of a network of contract service laboratories that offers pharma development, biologics testing and characterization, quality control testing, and biosafety—is implementing new capacity and capabilities in order to further boost its biologics testing services for the American biopharma market.1 The new project will be centered around SGS’ Lincolnshire Center of Excellence, […]

Continue Reading

AI’s Promise in Delivering on Patient-Centricity, What’s Complicating Good Data Practices and Data Integrity? & more

AI’s Promise in Delivering on Patient-Centricity How pharmaceutical companies can utilize AI at key stages of the treatment journey to enhance patient-centric engagement by increasing empathy and humanity in patient interactions. What’s Complicating Good Data Practices and Data Integrity? As the data management landscape continues to shift and change with AI and technological advancements all […]

Continue Reading

Reactions to New FDA Diversity Action Plan Guidance, Walgreens Strengthens Support for Children and Adults Living with Diabetes & more

Industry Leaders React to FDA’s Newly Announced Diversity Action Plan Guidance Pamela Tenaerts, MD, MBA, chief scientific officer, Medable; Luke Gelinas, PhD, senior chair director, Advarra; and Pam Diamond, MD, chief medical officer & co-founder, Curavit share their initial thoughts on the announcement of FDA’s Diversity Action Plan guidance. How Integrating Research Into Private Pharmacy […]

Continue Reading

Annual Life Sciences Good Manufacturing Practices Master Class 2024, FDA Grants Marketing Authorization for Rapid Hep C Test

What Needs to be Done to Cover GLP-1? In this part of his Pharmaceutical Executive video interview, Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, and what needs to be done […]

Continue Reading

Comparing Bariatric Metabolic Surgery, Glucagon-Like Peptide-1 Receptor Agonists Mortality Among Patients with Obesity and Diabetes

Image Credit: Adobe Stock Images/JuanGartner.com Obesity is considered a chronic relapsing disease described by adiposopathy, pathogenic changes that can impact multiple systems of the body.1 There is an existing association linking obesity with overall mortality, cardiovascular mortality, and a shorter life expectancy,2 which draws greater attention to how valuable the of implementation of applicable interventions would […]

Continue Reading

Comparing Bariatric Metabolic Surgery, Glucagon-Like Peptide-1 Receptor Agonists Mortality Among Obesity and Diabetes Patients

Image Credit: Adobe Stock Images/JuanGartner.com Obesity is considered a chronic relapsing disease described by adiposopathy, pathogenic changes that can impact multiple systems of the body.1 There is an existing association linking obesity with overall mortality, cardiovascular mortality, and a shorter life expectancy,2 which draws greater attention to how valuable the of implementation of applicable interventions would […]

Continue Reading

Semaglutide Associated with Optic Neuropathy That Can Lead to Blindness, FDA Approves Lilly’s Kisunla & more

FDA Approves Lilly’s Kisunla for the Treatment of Early Symptomatic Alzheimer’s Disease Kisunla is the first amyloid plaque-targeting therapy that allows for stopping treatment upon plaque removal, company says. Semaglutide Associated With Optic Neuropathy That Can Lead to Blindness, Mass Eye and Ear Researchers Report The active ingredient in Ozempic and Wegovy is linked to […]

Continue Reading

Genezen Purchases uniQure’s Gene Therapy Operations in Massachusetts

Image Credit: Adobe Stock Images/RadomirJovanovic.com Genezen, a gene therapy contract development and manufacturing organization (CDMO), will be acquiring uniQure’s commercial gene therapy operations in Lexington, MA, which adds a manufacturing plant and a team of employees into the mix.1 Per the deal, Genezen would enter into strategic supply agreements for both uniQure’s clinical portfolio and CSL’s […]

Continue Reading

FDA Approves Pyzchiva for Use in the United States

Image Credit: Adobe Stock Images/Gefo.com Based on the presented evidence—including clinical studies showing that it has “equivalent efficacy and comparable safety” as its reference medicine—the FDA has approved Sandoz’s branded biosimilar, Pyzchiva (ustekinumab-ttwe) 45 mg/0.5 mL and 90 mg/mL pre-filled syringes for subcutaneous injection; 130 mg/26 mL (5 mg/mL) single-dose vial for intravenous infusion for subcutaneous injection; […]

Continue Reading

Aurigene, Edity Introduce Cell Therapy Collaboration

Image Credit: Adobe Stock Images/PinkEyes.com Aurigene Pharmaceutical Services Limited, a contract research, development, and manufacturing services organization (CRDMO), will be offering discovery services to Edity Therapeutics Limited in the field of cell therapy.1 According to Edity—a company with various product candidates in the autoimmune disorders, gene therapy, oncology, and regenerative medicine spaces—it has designed a […]

Continue Reading

Analyzing the Effects of Respiratory Syncytial Virus Pre- and Post-Pandemic

Image Credit: Adobe Stock Images/Png-Jpeg-Vector.com Currently, respiratory syncytial virus (RSV) infection is the leading cause of hospitalization of young children as a result of respiratory complications of apnea, bronchiolitis, and pneumonia.1 Prior to the COVID-19 pandemic, more than two million children 5 years of age or younger in the United States needed medical care for RSV […]

Continue Reading

Veranova Expands Its Financial Commitment Toward Growing Highly Potent API Services

Image Credit: Adobe Stock Images/LoveEmployee.com Veranova, a manufacturer and developer of specialist and complex active pharmaceutical ingredients (APIs) for the pharmaceutical and biotech sectors, has begun to expand its antibody-drug conjugate (ADC) and highly potent compound development and manufacturing capabilities at its Devens, MA facility.1 The FDA-approved site that has over a decade of experience […]

Continue Reading

Kite to Assess Cellares’ Automated Manufacturing Platform

Cellares’ Cell Shuttle. Image Credit: Cellares Cellares, an integrated development and manufacturing organization (IDMO) that focuses on clinical and industrial-scale cell therapy manufacturing, recently revealed that Kite, a Gilead company, will be assessing its automated manufacturing platform, the Cell Shuttle.1 During this “proof-of-concept” evaluation, the data that is gathered will help Kite in determining the […]

Continue Reading

Novo Nordisk Invests $4.1 billion to Expand US Manufacturing, Improving the Efficacy of Genetic Medicines & more

Improving the Efficacy of Genetic Medicines Shawn Davis, CEO of Liberate Bio, shares some insights into the world of drug discovery, development, and delivery, as well as process optimization. Experts Discuss Serious Adverse Events for GLP-1 Medications Potential concerns surrounding GLP-include pancreatitis, pancreatic cancer, colorectal cancer, suicide and other phycological effects, and thyroid cancer. Welcome […]

Continue Reading

How to Thrive in a Cookie-Less Era, Why Consumers are Switching Providers and Payers & more

How Pharma Marketers Can Thrive in a Cookie-Less Era David Minkin, President & GM at epocrates, offers his insights into the importance of trust, first-party data, and strategic partnerships in ensuring successful marketing campaigns. Why Consumers are Switching Providers and Payers Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, […]

Continue Reading

Pharmacy Deserts & Underserved/Rural Communities, GoodRx Launches New “Prescription Cost Tracker” & more

Pharmacy Deserts & Underserved/Rural Communities In this part of his Pharmaceutical Executive video interview, Michael Abrams, Managing Partner, Numerof & Associates, speaks about the specific challenges that pharmacy deserts becoming a national issue presents for rural and underserved areas. Plus a discussion of which alternative solutions can help ensure continued access to medications for all. […]

Continue Reading

Pharmacy Closure Contributors, The Long-Term Consequences & more

Pharmacy Closure Contributors & Long-Term Consequences In this part of his Pharmaceutical Executive video interview, Michael Abrams, Managing Partner, Numerof & Associates, identifies the main factors contributing to closures of pharmacies big and small and some potential long-term consequences for public health if they continue. Public Health Matters: Generative AI and the Future of Pharmacy […]

Continue Reading

Novo Nordisk Financially Commits $4.1 Billion Toward Growing US Manufacturing Capabilities

Image Credit: Novo Nordisk As noted in a recent Pharma Pulse,1 Novo Nordisk plans invest $4.1 billion toward the construction of a second fill-finish manufacturing plant in Clayton, NC, which will expand the company’s efforts in to creating injectable treatments for individuals with obesity and other chronic diseases.2 The 56-acre project is expected to add […]

Continue Reading

The Association Between 340B Program Involvement and Availability of Hospital Services

Image Credit: Adobe Stock Images/VILevi.com The purpose of Medicaid’s 340B Drug Pricing Program is to grant the participating safety-net hospitals and clinics with incentives—in the form of discounts—from pharma companies on certain outpatient drugs, while billing insurers general reimbursement rates. In other words, says the Health Resources & Services Administration, the goal is to “stretch […]

Continue Reading

Charles River, Gates Institute Strike Lentiviral Vector Manufacturing Deal

Image Credit: Adobe Stock Images/Ayesha.com Charles River Laboratories International, Inc., a contract development and manufacturing organization (CDMO), and the Gates Institute at the University of Colorado Anschutz Medical Campus have reached a lentiviral vector manufacturing agreement.1 Per the deal, Gates Institute will utilize Charles River’s cell and gene therapy (CGT) expertise—especially in the manufacturing space—to develop good manufacturing practice (GMP)-grade lentiviral […]

Continue Reading

Investigating the Cost-Effectiveness of Durvalumab

Image Credit: Adobe Stock Images/iDoPixBox.com When it comes to the treatment of unresectable locally advanced stage III non–small cell lung cancer (NSCLC), the standard of care process features definitive chemoradiotherapy, followed by maintenance immunotherapy with durvalumab. In these instances, the obstacle is durvalumab’s cost of use in health systems, along with access, health system approvals, […]

Continue Reading

DIA 2024 Coverage, How Orange Peels Connect to Heart Health & more

DIA 2024: Gareth Dabbs of IQVIA Discusses Challenges With Clinical Technology In an interview with editor Andy Studna at DIA 2024, Dabbs, vice president, global product strategy, IQVIA highlights challenges with tech overload and how stakeholders can choose which solution(s) are best for their studies. Exploring the Connection Between Orange Peels, Gut Metabolism, and Heart […]

Continue Reading

Ascidian Therapeutics, Roche Enter RNA Exon Editing Therapeutics Collaboration

Image Credit: Adobe Stock Images/Nina.com Ascidian Therapeutics, a biotech company, has entered a research collaboration and licensing agreement with Roche for the discovery and development of RNA exon-editing therapeutics that target neurological diseases.1 Ascidian—whose efforts revolve around rewriting RNA—has an RNA exon editing platform that is intended to further the benefits of RNA medicine by […]

Continue Reading

Global Mortality and Disability from Type 1 Diabetes Have Decreased, What Leaders of Effective Teams Know & more

What the Leaders of the Most Effective Teams Know Findings from hundreds of interviews of exceptional pharma leaders around the world. Global Mortality and Disability from Type 1 Diabetes Have Decreased Global mortality fell 13 times faster in countries with a high sociodemographic index compared with countries with a low-middle sociodemographic index. Improve Site Experience […]

Continue Reading

Navigating Market Access Hurdles

In this exclusive PC Podcast interview, Mark Bouck, chairman and CEO of PharmAlliance, a pharmaceutical and life sciences services platform, dives into: How PharmAlliance’s acquisition of Complete Health Economics Outcomes Research Solutions (CHEORS) helps expand global reach The platform’s biggest goal to when it comes to CHEORS and market access services How CHEORS helps navigate […]

Continue Reading

Abzena, Argonaut Form Drug Development Alliance

Image Credit: Adobe Stock Images/MPStudio.com Abzena, a contract development and manufacturing organization (CDMO) for complex biologics and bioconjugates, and Argonaut Manufacturing Services, Inc., a current good manufacturing practice (cGMP) CDMO that operates in the diagnostics and biopharmaceutical and diagnostics sectors, have decided to partner up to design a fully integrated drug substance and drug product […]

Continue Reading

Bora Pharmaceuticals to Purchase Emergent’s Sterile Manufacturing Facility

Image Credit: Adobe Stock Images/iKatod.com As part of the company’s commercial plan, Bora Pharmaceuticals Co., Ltd., a contract development and manufacturing organization (CDMO), will be acquiring Emergent BioSolutions’ 87,000 square-foot sterile manufacturing facility in Baltimore-Camden, MD.1 The current site’s staff will also have the option to join the Bora team if they elect to do […]

Continue Reading

Do Medicare Hospital Admit a Representative Number of Beneficiaries Based on Their Respective Market Areas?

Image Credit: Adobe Stock Images/IFoto.com Racial inequalities—and their impact on health outcomes—can be influenced by treatment differences due to a change in clinical practices according to location, implicit bias, limited access to care, social determinants of health, and systemic and historical racism. Over the years, there has been a larger light being shined on how […]

Continue Reading

The Healthcare System is Changing—So How Should We Respond?, What the Apple-OpenAI Deal Means for Four Tech Titans & more

The Healthcare System is Changing—So How Should We Respond? What pharma needs to do to keep up with the rise in value-based care. How Stepped Palliative Care Can Improve Quality of Life for Lung Cancer Patients In a randomized clinical trial, the effectiveness of a stepped-care model for delivering palliative care to patients with advanced […]

Continue Reading

Weight Loss Drug Shortages Prompt Shortage Tracking Platforms, Build Trust with Patients to Overcome Misinformation & more

Weight Loss Drug Shortage Prompts Multiple Companies to Launch Shortage Tracking Platforms Hypermedica and Ro announced platforms to help patients find access to affordable weight loss medications. Building Trust with Patients to Overcome Misinformation | AHIP 2024 Geeta Nayyar, M.D., a rheumatologist and author, discusses how misinformation and disinformation is eroding the trust between doctors […]

Continue Reading

Exploring the Concept of Dynamic Pricing

PC: You recently penned your first byline, which has appeared in the June issue of Pharma Commerce. What does it discuss? Powers: What I’m doing here in the first write up is really contemplating digital platforms and dynamic pricing models, and what they’ve accomplished in other sectors. And really having an objective look about what it […]

Continue Reading

Wacker Introduces mRNA Competence Center in Germany

Wacker Biotech, a therapeutic protein contract manufacturer, recently opened up an mRNA competence center at its biotech site in Halle (Saale), Germany.1 The new facility—which broke ground in 20222 and was funded for $107 million—has the capability to handle large-scale manufacturing of active ingredients based on messenger ribonucleic acid (mRNA), including mRNA vaccines to combat […]

Continue Reading

Solving Challenges Within the Pharma Supply Chain

Image Credit: Adobe Stock Images/Pornfa.com In a recent webinar1 hosted by Systech, a provider of digital identification and traceability solutions, and IDC, a market intelligence firm, the speakers were brought together in an effort to address the challenges presented by the pharmaceutical supply chain. Titled “Solving the pharmaceutical supply chain challenges,” moderator Sreedhar Patnala, Systech’s […]

Continue Reading

Discovery Life Sciences Builds New Site in Greater Boston Area

Image Credit: Berkeley Investments Discovery Life Sciences, a provider of biospecimen solutions and laboratory services, is opening a new 53,000 square-foot office and laboratory site in Malden, MA.1 This specific facility marks the company’s seventh facility in the United States—its third in the Greater Boston area—alongside its Woburn and Quincy locations. The Malden plant is intended to directly benefit the pharma and biotech […]

Continue Reading

Determining the Source of Endocrine Therapy Nonadherence

Image Credit: Adobe Stock Images/GraphicRoyalty.com Estrogen receptor–positive (ER+) breast cancer—which is when cancer cells with receptors attach to estrogen—make up more than 70% of all breast cancer diagnoses. Receptors must be found in more than 10% of cancers in order to be considered ER.+ To combat this, the use of endocrine therapy, along with the […]

Continue Reading

eCTD 4.0: Implementation Best Practices

The creation of the electronic common technical document (eCTD) revolutionized the pharmaceutical regulatory submission process. It enabled the phasing out of paper-based processes, bringing much needed speed, reliability, and efficiency to global regulatory submissions. As the standard format for submitting regulatory applications, supplements, and amendments, eCTD is accepted by health authorities around the world, such […]

Continue Reading

Kyowa Kirin to Construct New Biologics Manufacturing Facility in North Carolina

A digital rendering of the south facade of Kyowa Kirin’s manufacturing facility. Image Credit: Kyowa Kirin Kyowa Kirin, Inc., a global specialty pharmaceutical company and affiliate of Kyowa Kirin Co., Ltd, will be financially committing up to $530 million for the construction of a new, state-of-the-art manufacturing facility in Sanford, NC.1 With construction expected to begin in the […]

Continue Reading

Do Medicare Advantage Plans with Supplemental Benefits Result in Better Plan Ratings?

Image Credit: Adobe Stock Images/Wladimir1804.com When it comes to the older adult demographic, there is an association between social service investments—such as income support, nutrition assistance, and housing support—and a decrease in medical care costs and improvements in health. As noted by the authors of a study published in JAMA Network Open,1 medical investments have […]

Continue Reading

Pharmaceutical Commerce – June 2024 Issue (PDF)

Pharmaceutical Commerce – June 2024 Issue (PDF) ‘Maturity’ Matters: Fortifying Two Key Cogs of Pharma Supply Chain Dynamic Pricing: What Pharma Needs? Combining RWE and AI to Bend the Adherence Curve Justifying Price Fairness How Serious Are You About Patient Centricity? Medicine for the Planet: Building a Sustainable Legacy in Pharma Supply Chains The Need […]

Continue Reading

Mark Cuban Talks Drug Pricing, Cost Remains Barrier to Respiratory Care for Patients & more

Mark Cuban Talks Drug Pricing Now more than two years into launching his alternative and transparent drug payment model, the longtime entrepreneur, in an interview with Pharm Exec, discusses the prescription drug cost landscape and shares his recipe for true disruption to the pharma pricing machine. Cost Remains Significant Barrier to Respiratory Care for Patients […]

Continue Reading

Public Sentiments Toward Purchasing Foreign Vaccines During a Pandemic

Image Credit: Adobe Stock Images/Iryna.com If the COVID-19 pandemic could be boiled down to one lesson, it is the fact that vaccines played an effective role in limiting the spread of infectious disease. Sure, supply chain issues that impact manufacturing and distribution efforts can occur—alongside length regulatory approval processes—but no process is flawless. Interestingly enough, […]

Continue Reading

How Serious Are You About Patient Centricity?

Rising cost pressures demand more efficient operations. Micro-launches are creating shorter go-to-market runways. The continued rise of specialty drugs with small patient populations puts increased pressure on companies’ promotional efforts. In this landscape, there are many ideas for how to improve commercial focus and effectiveness. However, maximizing the impact of commercial efforts starts with putting […]

Continue Reading

Justifying Price Fairness

Global price comparisons for prescription drugs continue to draw the attention of politicians, medical groups, and patient organizations. WHO and lower-income countries advocate for income-based pricing to address their low levels of affordability. However, higher-income countries systematically use lower prices around the world to lower their prices through international price referencing. Is the US subsidizing […]

Continue Reading

Combining RWE and AI to Bend the Adherence Curve

It’s widely understood that poor adherence to prescribed medication regimens has far-reaching clinical and cost implications for all healthcare stakeholders. For example, patients who never start or don’t stay on prescribed treatments fail to control their symptoms and often experience disease progression and increased morbidity and mortality. Insurance companies end up paying for expensive medical […]

Continue Reading

A New Inizio Engage Agency

Image Credit: Adobe Stock Images/JK_kyota.com Inizio Engage, a strategic, commercial, and creative engagement partner that specializes in healthcare, is launching a new global experiential agency, Emota, thereby combining Ashfield Event Experiences (AEE) and WRG.1 The resulting agency is expected to provide a full portfolio of services and capabilities that serve the healthcare industry and global […]

Continue Reading

Critical Year Ahead for the 340B Drug Pricing Program

Image credit: Cagkan | stock.adobe.com The 340B Drug Pricing Program continued to evolve in 2023, and further changes may be forthcoming as a result of ongoing lawsuits and regulatory action. For years, the program has become increasingly controversial, due to a lack of consensus between covered entities1 and pharmaceutical manufacturers over the permissible scope of […]

Continue Reading

New pDNA Facility in the Works for Bionova Scientific

Image Credit: Bionova Scientific Bionova Scientific, a biologics contract development and manufacturing organization (CDMO) that was acquired by Asahi Kasei Medical,is dipping its toes into plasmid DNA (pDNA) production.1 This endeavor will be centered around a new development and manufacturing facility in The Woodlands, TX, which is close to Houston. Once the plant becomes operational […]

Continue Reading

The Impact of Medicare Part D Antidementia Medication Therapy Management on Adherence

Image Credit: Adobe Stock Images/MonkeyBusiness.com The umbrella term Alzheimer’s disease and related dementias (ADRD) is intended to include Alzheimer’s disease (AD) along with other forms of dementia, vascular contributions to cognitive impairment and dementia frontotemporal degeneration, mixed etiology dementias, and Lewy body dementia. In 2021, it was estimated that more than six million Americans aged […]

Continue Reading

Stevanato Group Inaugurates Cisterna di Latina Site

Cisterna di Latina, Italy. Image Credit: Adobe Stock Images/ValerioMei.com Stevanato Group, a provider of drug containment and delivery solutions, has officially introduced its Cisterna di Latina plant in Italy.1 The site is located a few miles from the Group’s plant in Latina, and covers an area of 700,000 square feet with about 200 people on […]

Continue Reading

Thermo Fisher Scientific Introduces New EU Ultra-Cold Facility

Image Credit: Thermo Fisher Scientific Thermo Fisher Scientific, a contract development and manufacturing organization (CDMO), has opened a new clinical and commercial ultra-cold facility in the EU,1 which not only grows its European clinical trial network, but helps speed up advanced therapy development. The new current good manufacturing practice (cGMP) facility in Bleiswijk, Netherlands offers both […]

Continue Reading

OpenAI Forms New Committee to Evaluate Safety/Security, Proposed FDA Rule Could Limit Pharmacy Compounding & more

Finding Hope with Clinical Trials Nick Slack, CEO and chairman for START Center for Cancer Research, discusses the complications that patients have getting enrolled in clinical trials. Proposed FDA Rule Could Limit Pharmacy Compounding On March 20, 2024, the FDA proposed a new rule that would create criteria for certain drug products or categories that […]

Continue Reading

FourKites Becomes Collaborator for Supply Chain Leaders Consortium

Image Credit: Adobe Stock Images/LeoWolfert.com FourKites, a real-time supply chain visibility provider, will become a collaborator in the Scheduling Standards Consortium (SSC); the company is considered the first participating real-time visibility platform.1 The SSC is intended to “simplify the integration of systems across the fragmented ecosystem between shippers, carriers, and intermediaries, and create a more efficient appointment scheduling […]

Continue Reading

Merck to Acquire EyeBio, Financial Burden of Private Healthcare Increased Over the Past Two Decades & more

FDA Grants Priority Review to Keytruda Combination as a First-Line Treatment for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma Priority review designation for Keytruda is based on promising results from the Phase II/III IND.227/KEYNOTE-483 trial, which demonstrated improved overall survival in patients with unresectable advanced or metastatic malignant pleural mesothelioma. Financial Burden of Private Healthcare […]

Continue Reading

Gen Z’s Passion for Skincare Falls Short on Sun Protection, A Long, But Promising Road Ahead in Clinical Trials & more

AI in Clinical Trials: A Long, But Promising Road Ahead Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more. Gen Z’s Passion for Skincare Falls Short on […]

Continue Reading

Understanding the Impact of the Veradigm Network on Value-Based Healthcare Delivery

As healthcare is moving toward the shared goal of improving patient care more economically, stakeholders across the spectrum are increasingly aligned with the principles of value-based care. This paradigm shift is particularly evident in biopharma, which plays a pivotal role in the American healthcare system’s transformation. As we navigate this transition, the complexity of healthcare […]

Continue Reading

Sterling Pharma Solutions to Invest $3 Million in Germantown, WI Plant

Image Credit: Sterling Pharma Solutions Website Sterling Pharma Solutions, a contract development and manufacturing organization (CDMO), is financially committing $3 million toward its Germantown, WI plant, in order to grow its integrated antibody-drug conjugate (ADC) development and manufacturing services.1 This expansion project opens up the door for the recruitment of more scientists, alongside the hiring of a full-time industrial […]

Continue Reading

Ensuring Product Integrity and Regulatory Compliance

Today’s global marketplace demands robust measures for maintaining both product integrity and adherence to strict regulatory frameworks. Serialization technology is at the forefront of these efforts. This evolving technology—through its sophisticated mechanisms—is enhancing the safety and reliability of products throughout their journey from production to consumer. Below, we’ll explore how advancements in serialization technology are […]

Continue Reading

Air Cargo Sustains Growth for Q2

The momentum continues for global air cargo demand—April 2024 data gathered by the International Air Transport Association (IATA) suggests that there has been “strong annual growth” in demand, as the industry continues through Q2.1 Total demand, which is measured in cargo tonne-kilometers (CTKs), increased by 11.1% compared to April 2023 levels (11.6% for international operations). […]

Continue Reading

Kuehne+Nagel Opens New Site in El Paso

Image Credit: Kuehne+Nagel Kuehne+Nagel has opened a new 363,000 square-foot facility in El Paso, TX.1 The plant, which is scheduled to open on Aug. 5, 2024 while also bringing 145 jobs to the area, consists of four warehouses from across the border that are essentially consolidated into one. Nearshoring—the concept of relocating business operations to […]

Continue Reading

CG Oncology Reveals Promising Results from Phase II CORE-001 Clinical Trial for the Treatment of BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer

Image Credit: Adobe Stock Images/Crystal light CG Oncology announced positive final results from its Phase II CORE-001 clinical trial of cretostimogene grenadenorepvec (an oncolytic immunotherapy) in combination with pembrolizumab for treating BCG-unresponsive high-risk non-muscle invasive bladder cancer (HR-NMIBC) with carcinoma in situ (CIS). Results indicated that at one year, the complete response (CR) rate was […]

Continue Reading

Global Insulin Delivery Systems Strategic Research Report 2024, A Fun and Insightful Exploration of Behavioral Science & more

A Fun and Insightful Exploration of Behavioral Science Sharing an entertaining dive into the origins, milestones, and future of behavioral economics—where lessons can be applied to clinical practice. A Conversation Veteran Healthcare Lobbyist Paul Kelly | DC Roundtable A limited pharmacy benefit manager (PBM) reform bill may be used as a “pay for” to offset […]

Continue Reading

Cyberattack at Ascension Hospitals Causing Delays in Patient Care, Optimizing Pharmaceutical Innovation Through AI & more

Using an Omnichannel Approach for a Successful Product Launch Inizio’s chief operations officer discusses how pharmaceutical companies are tailoring their product launch strategies to meet the diverse needs of stakeholders. Optimizing Pharmaceutical Innovation Through AI: A Pathway to Expedited Drug Discovery and Development Clinical trials are using AI to handle large and complex volumes of […]

Continue Reading

Resource Label Group Purchases Beyer Graphics

Image Credit: Adobe Stock Images/NewAfrica.com Resource Label Group, LLC, a provider of label and packaging solutions including pressure sensitive labels, pharmaceutical packaging, and radio frequency identification/near-field communication (RFID/NFC) technology, has acquired Beyer Graphics, a specialty pharmaceutical and healthcare packaging business.1 The company’s high-tech plant focuses on providing packaging solutions, including such as custom folding boxes […]

Continue Reading

Hims & Hers Announces Access to GLP-1 Injections, The Impact of the Presidential Election on Pharma & more

US Pharma and Biotech Summit 2024: The Impact of the Presidential Election Experts discuss how the upcoming election is impacting the pharma industry, and how either party’s victory could change the landscape in the following years. Study Results Find Mood and Sleep Disorders Negatively Impact Asthma Control Despite the finding, the authors suggest further research […]

Continue Reading

A Pharmacist’s Impact on Inclusive Health Care, ChatGPT Usage to Support Drug Development & more

Mapping Baseline ChatGPT Usage to Support Drug Development Despite limitations to its widespread use within healthcare, there is great potential for ChatGPT’s application in drug development. Multilingual Medicine: A Pharmacist’s Impact on Inclusive Health Care Patricia Gutierrez, PharmD, BCACP, CDE, aims to combat the challenges in culturally competent care with knowledge and love for her […]

Continue Reading

Implications for Drug Shortages and Patient Care,  How Businesses Are Customizing AI Models & more

US Pharma and Biotech Summit 2024: Bringing the Skillset of Generation Alpha to the Pharma Industry In an interview with Associate Editor Don Tracy, Carmen Villar, VP, ESG & Corporate Citizenship, Gilead Sciences discusses new skills that members of generation Alpha will bring to the pharma industry and potential struggles that they may face. Unraveling […]

Continue Reading

Pre-Approval Information Exchange to Accelerate Product Success, Walgreens Boots Alliance Sells Shares of Cencora & more

Leveraging Pre-Approval Information Exchange to Accelerate Product Success, Patient Access Alvana Maliqi, Cencora’s associate director of value and access strategy for its commercialization strategy & access solutions division discusses the current state of pre-approval information exchanges. New Biosimilars Continue to be Approved But Uptake Varies by Class A recent IQVIA report found that uptake of […]

Continue Reading

MilliporeSigma to Purchase Mirus Bio

MilliporeSigma, a contract development and manufacturing organization that functions as the United States and Canada life science business of Merck KGaA, will be acquiring Mirus Bio for $600 million.1,2,3 Mirus Bio specializes in the development and commercialization of transfection reagents, including TransIT-VirusGEN. When it comes to the production of viral vector-based gene therapies, transfection reagents are heavily […]

Continue Reading

Orna Therapeutics Enhances Circular RNA Capabilities, Acquires ReNAgade Therapeutics

Image Credit: Adobe Stock Images/NateeMeepian.com Orna Therapeutics, a biotechnology company that strives to design new classes of fully engineered circular RNA therapeutics (oRNA), has acquired ReNAgade Therapeutics.1 The company’s goal is to a “unlock the potential of RNA therapeutics,” specifically pertaining to delivery that demonstrated to multiple extra-hepatic cells in non-human primate (NHP) models over […]

Continue Reading

Biogen Agrees to Acquire HI-BIO for $1.15 Billion

Image Credit: Adobe Stock Images/ColorCrafts.com Biogen Inc. and Human Immunology Biosciences (HI-Bio), a clinical-stage biotech company focused on targeted therapies for patients with severe immune-mediated diseases (IMDs), have entered into a definitive agreement under which Biogen will be purchasing HI-Bio for $1.15 billion upfront and up to $650 million in possible milestone payments. As of now, […]

Continue Reading

TFF Pharmaceuticals, Cleveland Clinic to Move Their Influenza Vaccine Candidates into Preclinical Testing

Image Credit: Adobe Stock Images/LeighPrather.com Alongside Cleveland Clinic, TFF Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, will be advancing numerous multivalent universal influenza vaccines into preclinical testing.1 These vaccines reportedly protect against seasonal and pandemic viruses; the choice to send these candidates through into preclinical testing was based on the completion of formulation testing with stability […]

Continue Reading

Tower Cold Chain Submits Its First-Ever Sustainability Report

Image Credit: Tower Cold Chain Tower Cold Chain, who was recently interviewed by Pharmaceutical Commerce at LogiPharma Europe,1 has published its first Sustainability Report,2 which outines the company’s pledge to following environmental, social and governance (ESG) principles. The report also lays out the environmental benefits that come with using its passive temperature-controlled containers for the […]

Continue Reading

Astellas, YASKAWA Sign Cell Therapy MoU Powered by Robotics Technology

Image Credit: Adobe Stock Images/Funtap.com Astellas Pharma has signed a memorandum of understanding (MoU) with YASKAWA Electric Corporation, signifying early talks to design a cell therapy ecosystem with the use of pharmaceutical and robotics technology.1 Although this particular memorandum is legally non-binding and technically not required to be followed, both parties expect that it will […]

Continue Reading

Johnson & Johnson Purchases Proteologix for $850 Million

Image Credit: Adobe Stock Images/Lial88.com In an $850 million deal, Johnson & Johnson will be acquiring Proteologix, Inc., a privately-held biotech company that specializes in bispecific antibodies for immune-mediated diseases.1 There is also the opportunity for an additional milestone payment. The Proteologix portfolio features PX130, a bispecific antibody targeting IL-13 plus IL-22, which is in […]

Continue Reading

AstraZeneca to Build $1.5 Billion Antibody Drug Conjugates Manufacturing Plant in Singapore

Image Credit: Adobe Stock Images/Huenstructurebio.com AstraZeneca will be constructing a $1.5 billion manufacturing facility1 in Singapore for antibody drug conjugates (ADCs)—treatments that provide cancer-killing agents directly to cancer cells through via targeted antibody—which will further boost its current ADC portfolio. Design and construction are expected to begin by the end of this year, with full […]

Continue Reading

Cold Chain Solutions Supplement: Further Exploration of Pharma’s Temperature-Controlled Sector

Post LogiPharma, the editors of Pharmaceutical Commerce examine the trends and highlights that came out of the conference, specifically surrounding the cold chain solutions segment. This digital supplement offers an overview of this niche sector’s value to the industry, and through exclusive video interviews with key opinion leaders and session coverage, provides perspectives from subject […]

Continue Reading

Marketing Strategies for Reaching Diverse Audiences, 1 in 8 Adults Have Utilized a GLP-1 Medication & more

Healthcare Marketing Strategies for Reaching Diverse Audiences Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much […]

Continue Reading

Senators Propose $32 Billion in Annual AI Spending but Defer Regulation, Talkspace Expands Tele-Mental Health to Medicare & more

Leveraging Lessons from Commercialization and Distribution of Rare Products for Cell and Gene Therapy In an interview with Pharm Exec Associate Editor Don Tracy, Melissa Lattanzi, VP, Emerging Therapies, Cencora discusses ways that cell and gene therapy developers can follow examples from the commercialization and distribution of orphan drugs. Talkspace Expands Tele-Mental Health to Medicare […]

Continue Reading

Apple Watch’s Afib App certified by FDA, Learning Telehealth Platforms Benefits Pharmacy Students & more

US Pharma and Biotech Summit 2024: Artificial Intelligence and Machine Learning Through the Eyes of the FDA In an interview with Pharm Exec Associate Editor Don Tracy, Tala Fakhouri, Associate Director for Policy Analysis, FDA, discusses the use of artificial intelligence and machine learning in drug development. Learning Telehealth Platforms Shows Benefit for Pharmacy Students […]

Continue Reading

Overcoming Supply Chain Challenges

In this exclusive PC Podcast interview, Chip Davis, president and CEO of the Healthcare Distribution Alliance (HDA), a national organization that represents primary pharmaceutical distributors, discusses: The benefits of the Distribution Management Conference, and the value it provides for the industry A three-year check-in since his last chat with Pharmaceutical Commerce, including a look at […]

Continue Reading

Financially Supporting Pharma Innovation

Funding pharma and biotech innovation, Financial Times US Pharma and Biotech Summit 2024 It’s no secret that the funding of ground-breaking developments does not come cheap, but where in fact do these aforementioned funds come from? The Financial Times’ US Pharma and Biotech Summit 2024 in New York City carried on with a leaders’ panel centered around […]

Continue Reading

PharmaLogic Opens Radiopharmaceutical Production Plant in NYC

Image Credit: PharmaLogic PharmaLogic Holdings Corp., a contract development and manufacturing organization (CDMO) and provider of radiopharmacy solutions, has unveiled its radiopharmaceutical production and research facility in the Bronx, NY.1 Purchased in 2022, the facility has been renovated with brand-new equipment, an indicator of the CDMO’s serious interest in long-term radiopharmaceutical investment. “We’re proud to […]

Continue Reading

Sanofi Invests Over $1 Billion Toward French Biomanufacturing Efforts

Image Credit: Adobe Stock Images/Rarrarorro.com Sanofi is investing over $1 billion toward the creation of new bioproduction capacity at its sites in Vitry-sur-Seine (Val de Marne), Le Trait (Seine-Maritime), and Lyon Gerland (Rhône), all located in France. The new financial commitment is expected to create more than 500 jobs while boosting France’s ability to control the […]

Continue Reading

The Impact of Medicare Advantage Employer Group Waiver Plans, The Need for Stepped-Up Patient Support & more

Patient Treatment & Travel: The Need for Stepped-Up Support Drug manufacturers have a long-standing history of providing hub support to help patients navigate the path to product access, effectively utilize their insurance coverage, and understand what other support may be available. But for certain types of therapies, more is needed. The Impact of Medicare Advantage […]

Continue Reading

Sharp Services Grows Sterile Injectables Manufacturing Capacity with Expansion of Pennsylvania Plant

Image Credit: Adobe Stock Images/Hardvicore.com Sharp, a provider of commercial pharmaceutical packaging and clinical trial supply services, will be expanding its Macungie, PA plant in order to boost its production capacity for sterile injectables secondary packaging.1 The Macungie expansion project is expected to provide greater capacity for secondary packaging activities, including autoinjector/pen assembly and labeling; vial […]

Continue Reading

Sanofi, Novavax to Co-Commercialize COVID-19 Vaccine

Image Credit: Adobe Stock Images/Orkidia.com In an effort to continue expanding on its vaccine development portfolio, Sanofi will be entering into a co-exclusive licensing deal with Novavax.1 Per the agreement, Sanofi will own a co-exclusive license to co-commercialize Novavax’s current stand-alone adjuvanted COVID-19 vaccine across the globe (except where Novavax has existing partnership agreements, including […]

Continue Reading

Done Global Elevates Pharmacy Network to Help Address ADHD Medication Shortages

Image Credit: Adobe Stock Images/BillionPhotos.com Done., a provider of hybrid care solutions for attention deficit hyperactivity disorder (ADHD) along with other chronic psychiatric conditions, is boosting its pharmacy network to now involve partnerships with more than 30 pharmacies.1 The various collaborations will help better confirm that medication is accessible for all. Such partnerships aim to […]

Continue Reading

PCI Pharma Services Begins Expansion Project

Image Credit: Adobe Stock Images/Mahira.com PCI Pharma Services, a contract development and manufacturing organization (CDMO) and biopharma global outsourcing services provider that currently operates 30 sites across seven countries, has started installing new equipment for what will soon be a 50,000 square-foot, sterile fill-finish facility on its Bedford, NH campus. The installation project features a […]

Continue Reading

Veeva Rolls Out New Features While Transitioning Its CRM platform

Image Credit: Adobe Stock Images/DeemerwhaStudio.com Veeva, a provider of customer relationship-management (CRM) software to the life sciences industry, updated its customers on the unusual transition it is undergoing as an enterprise software provider. Because it wanted to leave its platform technology originally licensed from Salesforce.com, it announced at last year’s event that it would undertake […]

Continue Reading

Myonex Finalizes Creapharm Deal

Image Credit: Adobe Stock Images/JozefMicic.com Myonex, a clinical trial supply company,has now finalized the purchase of Creapharm’s pharmaceutical services business.1 The deal is expected to be beneficial for both pharma and biotech companies in the clinical and commercial stages; this also includes companies in the advanced therapies sector. Moving forward, Creapharm’s clinical packaging and distribution services, commercial […]

Continue Reading

Geodis’ Copenhagen Plant Awarded IATA CEIV Pharma Certification

Geodis, a transport and logistics company, is continuing to increase its temperature-controlled pharmaceutical shipment capabilities in Europe by being awarded the International Air Transport Association (IATA)’s Center of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV Pharma) certification for its Copenhagen location. Including this award, Geodis now has a total of 28 CEIV Pharma certified […]

Continue Reading

Are Smartphones Driving Teens to Depression? Does Pharma Know What Their Customers Really Want? & more

Hey Pharma–Do You Know What Your Customers Really Want? Running a healthcare practice is hard, filled with critical daily activities that aren’t covered in medical school. Patients need help with their insurance companies, staff needs help following up with patients—and everyone needs help navigating electronic health records. These pain points offer a prime opportunity for […]

Continue Reading

Teva and Alvotech Further Strengthen Their Relationship, Reach Biosimilar Commercialization Deal

Image Credit: Adobe Stock Images/Ahmad.com Teva Pharmaceuticals and Alvotech, a biotech company that specializes in the development and manufacture of biosimilars, have reached a US strategic partnership agreement.1 Per the deal, Alvotech is set to produce its high-concentration, interchangeable biosimilar to Humira—also known as adalimumab—for Quallent Pharmaceuticals, a private label pharma distributor. In other words, […]

Continue Reading

Astellas, Poseida Therapeutics Ink Allogeneic Cell Therapy Agreement

Image Credit: Adobe Stock Images/Catalin.com Xyphos Biosciences, Inc., a wholly owned subsidiary of Astellas Pharma, and Poseida Therapeutics, Inc, a clinical-stage biopharmaceutical company, have inked a research collaboration and license agreement that entails the development of novel convertibleCAR (convertible chimeric antigen receptor) programs.1 This will involve a combination of both parties’ cell therapy platforms. Poseida’s goal is […]

Continue Reading

Kenco, QPharma Collaborate on Improving Supply Chain Challenges

Image Credit: Adobe Stock Images/Kentoh.com Kenco, a provider of third-party logistics (3PL)—which happens to be a major area of coverage for Pharma Commerce—has partnered with QPharma, a cloud-based software company, to add pharmaceutical sample fulfillment to the 3PL’s life sciences division.1 Being heavily involved with commercial pharmaceutical fulfillment, the addition of this sample distribution capability […]

Continue Reading

A Look at the Effects of the Inflation Reduction Act

Image Credit: Adobe Stock Images/FormatOriginal.com One of the main purposes of the Inflation Reduction Act (IRA)—which passed in August 2022—is to lower prescription drug prices for Medicare enrollees and taxpayers. However, manufacturers are also incentivized to invest in post-approval activities for both oncology and cardiovascular drugs. In fact, the Medicare Drug Pricing Negotiation Program (DPNP) […]

Continue Reading

Air Freight Demand Continues Its Climb in March

According to the International Air Transport Association (IATA), March 2024 data for global air freight markets are continuing to present an upward trend, as demonstrated by favorable yearly growth in demand. Total demand, which is measured in cargo tonne-kilometers (CTKs), increased by 10.3% compared to last March’s levels (11.4% for international operations). This represents the […]

Continue Reading

Sygnature Discovery Given Award for Sustainability

The Sygnature Discovery team participating in the “Freezer Challenge.” Image Credit: Sygnature Discovery Sygnature Discovery, a drug discovery contract research organization (CRO), has earned a Bronze rating from EcoVadis, a sustainability ratings platform that assesses companies across multiple industries on environmental, social, and ethical performance criteria.1 In this specific instance, the CRO was acknowledged for […]

Continue Reading

Merck KGaA Financially Commits $322 Million Toward Research Center

Merck KGaA, a science and technology company, will be financially committing more than $322 million (€300 million) into a brand-new, 18,000 square-foot research center at its global headquarters in Darmstadt, Germany. Known as the “Advanced Research Center,” the company’s life science business branch plans on exploring solutions surrounding mRNA applications and manufacturing antibodies, along with […]

Continue Reading

Berry Global Increases Manufacturing Capacity

Image Credit: Berry Global Group, Inc. In an effort to surge its pharmaceutical production capabilities by as much as 30% across its European facilities, Berry Global Group, Inc., a contract development and manufacturing organization (CDMO) and provider of packaging solutions, is investing in a surplus of assets and manufacturing services. With locations in Offranville, France; […]

Continue Reading

The Relationship Between Cold Chain Logistics and Cell & Gene Therapies

Cell & gene therapies—often referred to as CGTs—are continuing to serve as gamechangers within our industry, due to their ability to treat complex diseases. Pharmaceutical Commerce sat down with Wilfredo Marin, senior product application scientist at Thermo Fisher Scientific, to discuss the ultra-low temperature (ULT) storage requirements surrounding CGTs, along with the flexibility for customization. Pharmaceutical Commerce: Could […]

Continue Reading

Walgreens Debuts Specialty Pharma Business

In an effort to further improve patient outcomes while also offering additional value to both payers and partners, Walgreens is launching Walgreens Specialty Pharmacy, a holistic service that aims to expand access to care for patients who have complex, chronic conditions.1 As a result, AllianceRx Walgreens Pharmacy will now become fully integrated, becoming part of […]

Continue Reading

Eli Lilly Purchases Nexus Pharmaceutical Injectables Manufacturing Plant

Image Credit: Adobe Stock Images/StoatPhoto.com Riding the momentum of its digital platform LillyDirect that will sell certain drugs directly to consumers with a prescription for conditions such as diabetes, obesity, and migraine,1 Eli Lilly and Company has acquired a Pleasant Prairie, WI manufacturing facility from Nexus Pharmaceuticals, a sterile manufacturer in the pharma sector.2 The […]

Continue Reading

Kühne Holding Inks Deal for Aenova

Image Credit: Adobe Stock Images/MonsterZtudio.com Kühne Holding AG, the holding company of third-party logistics provider Kuehne+Nagel, has agreed to purchase Aenova Group, a pharma contract development and manufacturing organization (CDMO), from BC Partners, an international investment firm. Although financial terms of the deal were not disclosed, BC Partners’ advised funds are expected to reinvest alongside Kühne […]

Continue Reading

FDA Issues Complete Response Letter to Abeona Therapeutics Regarding PZ-Cel for Recessive Dystrophic Epidermolysis Bullosa

Image Credit: Adobe Stock Images/M.Dörr & M.Frommherz The FDA has issued a Complete Response Letter (CRL) in response to Abeona Therapeutics’ Biologics License Application (BLA) for pz-cel (prademagene zamikeracel), a treatment for recessive dystrophic epidermolysis bullosa (RDEB). According to the letter, the agency expressed a need for additional Chemistry Manufacturing and Controls (CMC) information for […]

Continue Reading

Migraine Treatment Comes in Different Forms, State Level Legislation Impacting Patient Services & more

Covering State Level Legislation and Regulations Impacting Patient Services, Access, and Affordability In this Pharmaceutical Executive video interview, Jon Hamrick, Partner, Curatio Scientia Advisors and Jon Rawlson, President & Founder, Armory Hill Advocates, discuss what’s stopping companies from investing in covering state level legislation and regulations impacting patient services, access, and affordability. Migraine Treatment Comes […]

Continue Reading

FDA Approves ImmunityBio’s Anktiva for the Treatment of BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

Image Credit: Adobe Stock Images/Adin The FDA has approved ImmunityBio’s Anktiva (nogapendekin alfa inbakicept-pmln) for use in combination with Bacillus Calmette-Guérin (BCG) to treat BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with or without papillary tumors. According to the company, the approval was based on results from a single-arm, multicenter trial, […]

Continue Reading

Expanse Ice Receives FDA 510(k) Clearance for ICE Aspiration System for Peripheral Arterial, Venous Systems

Image Credit: Adobe Stock Images/Dr_Microbe Expanse ICE announced that its ICE Aspiration System has received 510(k) clearance from the FDA. According to the company, the system treats venous thromboembolism (VTE), which affects nearly one million patients annually in the United States, with 33% experiencing long-term complications. The ICE Aspiration System works by combining proficiencies of […]

Continue Reading

Obstacles Surrounding Personalized Therapy Supply Chains

LogiPharma Europe 2024 session, “How can you implement scalable networks to overcome the challenges of complex supply chains for personalized therapies?” April 17, 2024. LogiPharma Europe 2024, Lyon, France. Image Credit: Nicholas Saraceno Cell and gene therapies (CGTs) are becoming more of a focus for Pharmaceutical Commerce, especially given the fact that many of them […]

Continue Reading

Properly Applying Diversity, Equity, and Inclusion Initiatives Within the Life Sciences Supply Chain

LogiPharma Europe 2024 session, “How can Diversity, Equity, and Inclusion (DE&I) initiatives within the life sciences supply chain effectively address systemic biases, drive performance and effectively improve innovation, ethical standards, and global healthcare access?” April 18, 2024. LogiPharma Europe 2024, Lyon, France. Image Credit: Nicholas Saraceno Many could make the argument that diversity, equity, and […]

Continue Reading

FDA Approves Takeda’s Subcutaneous Form of Entyvio as a Maintenance Therapy in Adults with Moderately to Severe Crohn Disease

Image Credit: Adobe Stock Images/valiantsin The FDA has approved Takeda Pharmaceuticals’ subcutaneous (SC) form of Entyvio (vedolizumab) as a maintenance therapy for adults with moderately to severely active Crohns disease (CD) following initial intravenous (IV) induction therapy. The expanded approval for an SC form of the drug was based on results from the randomized, double-blind, […]

Continue Reading

The Real Cost of State Drug Importation Programs, Millions in Africa Will Miss HPV Shots After Merck Production Problem & more

Check out our coverage from LogiPharma Europe 2024 The Real Cost of State Drug Importation Programs? Patient Safety Importing drugs from Canada may increase the risk of US citizens being exposed to unsafe medicines. Talking About the Generations:The health and healthcare of boomers, Gen Xers, millennials and Gen Zers. Part 4, Gen Z. Generation Z […]

Continue Reading

Genentech Shares Promising Results from Phase III OCARINA II Study of Ocrevus for Elapsing, Primary Progressive Multiple Sclerosis

Image Credit: Adobe Stock Images/Worldillustrator Genentech announced promising one-year results from the Phase III OCARINA II study, which evaluated Ocrevus (ocrelizumab) in the treatment of patients with both relapsing and primary progressive multiple sclerosis (RMS or PPMS). According to the results, a twice-yearly injection of Ocrevus produced near-complete suppression of clinical relapses and major reductions […]

Continue Reading

Certain Biotech Investors Get an Early Look at Results, An Ethical Outlook for Obesity Drugs & more

Check out our coverage from LogiPharma Europe 2024 An Ethical Outlook for Obesity Drugs In this Pharmaceutical Executive video interview, Currax Pharmaceuticals, CEO, George Hampton, discusses what to expect from the obesity space in the next five years. It’s Not Just Congress. There’s Plenty of State-Level Action on PBMs, Drug Costs and Prices | AMCP […]

Continue Reading

Novartis’ Fabhalta Shows Significant Promise in Reducing Proteinuria in Patients with IgA Nephropathy

Image Credit: Adobe Stock Images/Stock Pix Novartis revealed promising data from an analysis of its Phase III APPLAUSE-IgAN trial evaluating Fabhalta (iptacopan) in patients with IgA nephropathy (IgAN). According to the study results, patients treated with Fabhalta demonstrated a 38.3% reduction in proteinuria after 9 months when compared to a placebo. The findings were shared […]

Continue Reading

LogiPharma Europe 2024: A Digital Capability Transformation

LogiPharma Europe 2024 session, “How can you transform digital capabilities in your temperature- controlled supply chain to improve visibility, quality and reactivity?”” April 16, 2024. LogiPharma Europe 2024, Lyon, France. Image Credit: Nicholas Saraceno One of several focuses at this year’s LogiPharma Europe—cold chain—was on full display at a panel discussion titled “How can you […]

Continue Reading

Diabetes Weight Loss Drugs Could Reduce Risk of MS, Walmart Health Expands in Texas & more

Rare Disease Summit Recap Greater Than One’s Chief Strategy Officer, Andrew Bast, came away from the 2024 Rare Disease Summit in Philadelphia, PA, held this year on March 18th-21st, feeling empowered and inspired. Miranda Schmalfuhs recently connected with him for a Q&A on his experience and what takeaways he found most fascinating and profound. Diabetes […]

Continue Reading

Trial Findings for Minimally Invasive Parafascicular Technology Show Promise for Intracerebral Hemorrhage Treatment

Image Credit: Adobe Stock Images/Dr_Microbe NICO Corporation announced that results from the ENRICH trial testing minimally invasive parafascicular surgery (MIPS) technology for intracerebral hemorrhage (ICH) show the procedure is safer than current methods of medical management. The results, published by the New England Journal of Medicine, indicated that early MIPS interventions using the company’s BrainPat […]

Continue Reading

Increase in ransomware attacks to healthcare’s remote access systems, The Health and Healthcare of Gen Xers & more

The Role of Human Oversight With Artificial Intelligence in Clinical Research Stephen Pyke, chief clinical data and digital officer, Parexel, highlights the importance of human oversight when using artificial intelligence to aid in decision making. Talking About the Generations: The Health and Healthcare of Boomers, Gen Xers, millennials and Gen Zers. Part 2, Gen Xers […]

Continue Reading

Ascend Acquires Beacon Gene Therapy Manufacturing Site

Image Credit: Adobe Stock Images/XaMaps.com Ascend Advanced Therapies, a gene therapy development partner, has purchased Beacon Therapeutics’ contract, manufacturing, and controls team—along with the company’s site located in Alachua, FL—a town considered to be a “biotech hub” in the state.1 The acquisition introduces a good manufacturing practice (GMP) plant into the fold, along with process and analytical development […]

Continue Reading

7% of Patients with Cancer Participate in Research, Technologies Being Used to Enhance Trial Enrollment and Diversity & more

What Digital Technologies are Being Used to Enhance Clinical Trial Enrollment and Diversity? Systematic review of research articles sought to identify and characterize different technologies being used in clinical studies. 7% of Patients with Cancer Participate in Treatment Research New study finds trial enrollment was highest at NCI-designated cancer centers. Researchers said more needs to […]

Continue Reading

Pharma Strategies for Succeeding Amid Strong Headwinds

Image credit: Africa Studio | stock.adobe.com High inflation and a volatile market have caused a perfect storm for the pharmaceutical industry. How companies respond will make all the difference in not only surviving but thriving in the face of macroeconomic headwinds. Weathering the storm will involve strategies that differ depending on whether you are a small, mid-sized, or large pharma company. The […]

Continue Reading

The Road Ahead for GenAI-Enabled/Augmented Clinical Trials, The Health and Healthcare of Boomers & more

Generative AI-Enabled/Augmented Clinical Trials: The Road Ahead The current clinical development model is shifting toward a generative AI-augmented proactive approach supported by real-world data for real time evidence. Talking About the Generations: The Health and Healthcare of Boomers, Gen Xers, Millennials and Gen Zers. Part 1, The Boomers Tne Boomers (1946–1964): Active but aging Kenvue […]

Continue Reading

Mitigating Drug Shortages

In this exclusive PC Podcast interview, Allen Jacques, a life sciences industry thought leader at Kinaxis, dives into: What he sees as limitations of current government efforts when it comes to boosting domestic production of essential medicines, and why they aren’t sufficient How and why drug shortages occur The challenges that generic drug manufacturers are […]

Continue Reading

In Battle Over Health Care Costs, Private Equity Plays Both Sides, Psychedelic Medicine Could Fill Care Gap & more

Expanding Access to Fight the Obesity Epidemic In this Pharmaceutical Executive video interview, Currax Pharmaceuticals, CEO, George Hampton, discusses how access to these weight loss drugs can help the obesity epidemic. Psychedelic Medicine Could Fill Care Gap in Psychiatric Care However, psychedelic medicine has a variety of barriers, including historical perception, access challenges, legal obstacles, […]

Continue Reading

Maersk Welcomes New Facility in Sri Lanka

Maersk has officially welcomed its brand new 100,000 square-foot warehouse in Wattala, Sri Lanka.1 Vikash Agarwal, managing director, Maersk South Asia; Biju Ravi, head of Maersk Sri Lanka; and Dr Parakrama Dissanayake, deputy chairman & managing director, Aitken Spence PLC, among others, were present for the occasion. According to company officials, the new plant affirms […]

Continue Reading

How Efficient Logistics Can Change the Lives of Rare Disease Patients

Danial Arkwell, PhD, head of Global Key Accounts, Pharma at Envirotainer. There are approximately 8000 rare diseases in the world and many of these are chronic, life-threatening conditions.1 To fight these elusive illnesses, the medical community focuses on developing specialised medications known as orphan drugs. Originating from the United States Orphan Drug Act (ODA) in […]

Continue Reading

Tower Cold Chain Partners with ELPRO, Debuts Near Real-Time Tracking and Monitoring Feature

Tower’s parcel-sized KTEvolution in the 27 and 56-liter sizes. Image Credit: Tower Cold Chain With the help of ELPRO—a provider of temperature monitoring solutions for the pharmaceutical and life science industries—Tower Cold Chain has launched a new, live tracking feature.1 According to the company, this new partnership is expected to further improve Tower’s advanced passive temperature-controlled […]

Continue Reading

DeSpir Logistics Officially Accredited by HDA, PCSC Good Distribution Practices Accreditation Program

Image Credit: Adobe Stock Images/Aree.com DeSpir Logistics, a third-party logistics provider (3PL) for time-sensitive mission-critical cargo and a “Fast 50 Company,”1 has completed the Healthcare Distribution Alliance (HDA) Good Distribution Practices (GDP) Accreditation Program, making it the first organization to do so.2,3 The program is designed to offer links in the pharma supply chain with the opportunity […]

Continue Reading

Is 2024 the Year for Psychedelic Medicine? Barriers Impacting Enrollment in Lung Cancer Trials & more

Barriers Impacting Patient Enrollment in Lung Cancer Trials Systematic review of available literature aimed to identify the most prominent barriers affecting enrollment in oncology drug trials. Is 2024 the Year for Psychedelic Medicine? MDMA-assisted therapy and psilocybin currently lead the way with potential approvals by the FDA. Patient With Transplanted Pig Kidney Leaves Hospital for […]

Continue Reading

Logistics4Pharma Unveils Dry Shipper with -196°C Storage Capabilities

Image Credit: Adobe Stock Images/ID_Anuphon.com Logistics4Pharma, a pharmaceutical cold chain packaging, storage, warehousing, and logistics provider that will be exhibiting at this month’s LogiPharma Europe, is growing its services offering at its Kelsterbach, Germany plant by welcoming dry shippers into the fold.1 Dry shippers—also known as cryoshippers—are thermal containers with an inlay that absorbs liquid […]

Continue Reading

McKesson Debuts Project Oasis to Increase Patient Accessibility to Pharmacies

Image Credit: Adobe Stock Images/ShermanCahal.com McKesson Corporation—one of the drug wholesaling world’s “Big Three”—is launching Project Oasis, which is a new initiative whose goal is to further health equity for at-risk populations that live in underserved communities.1 Project Oasis works to find and draw attention to pharmacy deserts, specifically in urban areas where residents may […]

Continue Reading

McKesson Debuts Project Oasis to Increase Accessibility to Pharmacies

Image Credit: Adobe Stock Images/ShermanCahal.com McKesson Corporation—one of the drug wholesaling world’s “Big Three”—is launching Project Oasis, which is a new initiative whose goal is to further health equity for at-risk populations that live in underserved communities.1 Project Oasis works to find and draw attention to pharmacy deserts, specifically in urban areas where residents may […]

Continue Reading

Air Cargo Sustains Significant Growth for February

As noted by the International Air Transport Association (IATA), February 2024 data suggests that air cargo markets showing are continuing to ride momentum, as demonstrated by the yearly rise in demand. Global air cargo demand, which measured in cargo tonne-kilometers (CTKs), saw an uptick of 11.9%, compared to last February’s numbers (12.4% for international operations). This […]

Continue Reading

Pharmaceutical Commerce – April 2024 Issue (PDF)

Pharmaceutical Commerce – April 2024 Issue (PDF) Cold Chain, PBMs, and More Looking Ahead to LogiPharma Europe An ‘Access’ Double-Take: Fresh Views on PAPs and Patient Hubs The Pharma Cold Chain: More Visible, More Sustainable—and Colder The Power of Patient Adherence Tools to Improve the Patient Journey Tackling Patient-Related Challenges Along the Pharma Supply Chain […]

Continue Reading

More Visible, More Sustainable—and Colder

Addressing the needs of the life sciences industry for reliable, cost-effective cold chain solutions remains fertile ground for developing new technologies. Even after a decade or so of advances in insulation, refrigeration techniques, and packaging innovation, new challenges are arising: chief among these are better visibility (via data generation and transmission) of real-time actions in […]

Continue Reading

The Power of Patient Adherence Tools to Improve the Patient Journey

Healthcare journeys vary widely from patient to patient, impacted by unique factors such as age, gender, severity of symptoms, access to specialists, insurance coverage, and more. Amid these complexities, adherence to prescribed therapies emerges as a linchpin for achieving positive health outcomes. However, the healthcare industry continually grapples with persistently low adherence rates, posing a […]

Continue Reading